Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
03/2006
03/29/2006EP1638942A1 Cis-2,4,5-triaryl-imidazolines
03/29/2006EP1638941A1 Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
03/29/2006EP1638932A1 Novel piperazinyl-aryloxy and piperazinyl-heteroaryloxy-n-aryl lactams
03/29/2006EP1638568A2 Indole, azaindole and related heterocyclic n-substituted piperazine derivatives
03/29/2006EP1539745B1 N-aryl-2-oxazolidinones and their derivatives
03/29/2006EP1330453B1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents
03/29/2006EP0979823B1 Novel amide compounds and drugs containing the same
03/29/2006CN1753996A The gene cluster involved in safracin biosynthesis and its uses for genetic engineering
03/29/2006CN1753890A Benzoazolypiperazine derivatives having MGLUR1- and MGLUR5-antagonistic activity
03/29/2006CN1753888A Hydroxymethyl substituted dihydroisoxazole derivatives useful as antibiotic agents
03/29/2006CN1753887A Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
03/29/2006CN1753886A Process for producing acid adduct salt of polyacidic base compound
03/29/2006CN1753881A 4-(3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexyloxy)-butane acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis.
03/29/2006CN1753880A Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals
03/29/2006CN1753879A (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexylmethoxy acetic acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis.
03/29/2006CN1753876A New pyridazin-3(2h)-one derivatives
03/29/2006CN1753872A Process for the production of substituted nicotinic acid esters
03/29/2006CN1753679A Phthalazine derivatives as phosphodiesterase 4 inhibitors
03/29/2006CN1753677A Ocular hypotensive agent
03/29/2006CN1753671A 1,3-substitued cycloalkyl derivatives having acidic, mostly heterocyclic groups; processes for their preparation and their use as pharmaceuticals
03/29/2006CN1752084A Heterocycle containing fluorene kind derivative and its preparation method
03/29/2006CN1752078A Aibomycin analogue, its preparation method, medicinal composition and use
03/29/2006CN1247574C Isoindolin-1-one glucokinase activators
03/29/2006CN1247571C Novel 2H -pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient
03/28/2006US7019147 E.,g.,1-[2-(5-Methoxy-benzoimidazol-1-yl)-quinolin-8-yl]-piperidin-4-ylamine; anticarcinogenic and -tumor agent; KDR tyrosine kinase inhibitors; (KDR=kinase inserrt domain recepter)
03/28/2006US7019133 conducting a catalytic transesterification by reacting a low-carbon alkyl ester of mycophenolic acid with 2-morpholinoethanol to obtain a crude product of mycophenolate mofetil, which is then isolated and purified
03/28/2006US7019012 Quinazoline derivatives and pharmaceutical compositions containing them
03/28/2006US7019006 Compounds useful as anti-inflammatory agents
03/28/2006US7019005 3 (5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors
03/28/2006US7019004 Agonists of imidazolidine-2,4-dione derivatives, chemical intermediates, for treating anxiety, depression, schizophrenia, neurodegenerative diseases, dementia, epilepsy, endocrinological disorders associated with excess of hormone, tumor
03/28/2006US7019003 Bactericides
03/28/2006US7019001 Substituted benzothiazole amide derivatives
03/28/2006US7018998 substituted 4,5-dihydro-1H-benzo[b][1,4]-diazepin-2-one; amidation of a substituted monoprotected 1,2-diaminobenzene with an ester, deprotecting, cyclization; chronic neurological disorders, psychosis, schizophrenia, Alzheimer's disease
03/28/2006CA2395186C Procollagen c-proteinase inhibitors
03/28/2006CA2263417C Arylalkanoylpyridazines
03/28/2006CA2244862C Substituted amide derivatives
03/23/2006WO2006031782A2 Salvinorin derivatives as opioid receptor ligands
03/23/2006WO2006031556A2 Amidine substituted aryl aniline compounds
03/23/2006WO2006030975A1 Piperidine derivatives and use thereof
03/23/2006WO2006030892A1 Process for production of heterocyclic compounds
03/23/2006WO2006030807A1 Carbamoylpyridone derivative having hiv integrase inhibitory activity
03/23/2006WO2006030032A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
03/23/2006WO2006029912A1 Indole derivatives as antiviral agents
03/23/2006WO2006029906A1 Methylene dipiperidine derivatives
03/23/2006WO2005120148A3 Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases
03/23/2006WO2005082892A3 Triazole compounds as antibacterial agents and pharmaceutical compositions containing them
03/23/2006US20060063940 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
03/23/2006US20060063935 (4S)-3-((E)-2-butenoyl-4-benzyl-2-oxazolidinone;antocarcinogenic agent; controlling progression of cancer through metastasis in animal suffering from a colon, lung, or breast cancer; synergistic mixture with other chemotherapeutic agent or radiation
03/23/2006US20060063928 11-((4-(2-Carboxy-2-methylpropyl)-piperazin-1-yl)-benz/b,f/1,4-oxazepine and the hydrochloride addition salt; side effect reduction; sleep maintenance insomnia; sleep disorders; narcolepsy; circadian rhythm disorders; sleep apnea syndrome,and hypersomnia
03/23/2006US20060063843 Compounds for the treatment of inflammatory disorders
03/23/2006US20060063818 Hydantoin derivatives and deren verwendung als tace inhibitoren
03/23/2006US20060063796 Pyrazoles as inhibitors of tumor necrosis factor
03/23/2006US20060063782 3-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors
03/23/2006US20060063779 Pyridyl inhibitors of hedgehog signalling
03/23/2006US20060063772 New compounds
03/23/2006US20060063765 5-[({[({(2S)-4-[(3,4-dichlorophenyl)methyl]-2-morpholinyl}methyl)amino]carbonyl}amino)methyl]-N-methyl-3-furancarboxamide; free of N-{[4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}-N'-(2-furylmethyl)urea; CCR3/chemokine recetptor/ antagonists
03/23/2006US20060063763 Compounds and methods for modulating CXCR3 function
03/23/2006US20060063757 Sulfonamide derivatives as antipsychotic agents
03/23/2006US20060063756 Janus Kinase JAK2 and JAK3; 4-chloro-6-(3,5-dimethylpiperazin-1-yl)pyrimidine; chemotherapeutic, antiproliferative, antiinflammatory, immunomodulatory agent; allergies, asthma, autoimmune diseases, transplant rejection, rheumatoid arthritis, multiple sclerosis
03/23/2006US20060063751 Novel fused heterocycles and uses thereof
03/23/2006US20060063739 2-Substituted heteroaryl compounds
03/23/2006DE102004045648A1 Neue Betamimetika zur Behandlung von Atemwegserkrankungen New beta-mimetics for the treatment of respiratory disorders
03/23/2006DE102004036551A1 Dioxazinyl-substituierte Thienylsulfonylaminocarbonylverbindungen Dioxazinyl-substituted thienylsulfonylaminocarbonyl
03/23/2006CA2581144A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
03/23/2006CA2568832A1 Indole derivatives as antiviral agents
03/22/2006EP1637525A1 Benzoxazole compound, process for producing the same, and herbicides
03/22/2006EP1637138A2 Use of thiazolidinediones to prevent or delay onset of NIDDM
03/22/2006EP1636221A2 New azetidine compounds
03/22/2006EP1636220A1 Isoxazole and isothiazole compounds for the treatment of neurodegenerative disorders
03/22/2006EP1636216A1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
03/22/2006EP1636215A1 Furazanobenzimidazoles
03/22/2006EP1636207A1 Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase
03/22/2006EP1636193A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
03/22/2006EP1635829A1 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors
03/22/2006EP1635817A1 1-phenyl-2-oxo-3-sulfonylamino-pyrrolidine derivatives and related compounds as factor xa inhibitors for the treatment of acute vascular diseases
03/22/2006EP1480951A4 Synthesis of indole thiazole compounds as ligands for the ah receptor
03/22/2006EP1406891B1 Thiochromenones used to combat painful conditions and neurodegenerative diseases
03/22/2006EP1328509B1 Methods of producing oxazolidinone compounds
03/22/2006EP1140924B1 Piperazine derivatives
03/22/2006EP1029541B1 Therapeutic or prophylactic agent for glomerulopathy
03/22/2006CN1751055A Organic metal complex, electroluminescent material using the complex and ectroluminescent element using the complex
03/22/2006CN1751047A Triazole compounds useful in therapy
03/22/2006CN1751039A Pyridine derivatives as fungicidal compounds
03/22/2006CN1751038A Substituted aryl and heteroaryl derivatives as modulators of glucose metabolism and the prophylaxis and treatment of disorders thereof
03/22/2006CN1751037A Sulfonamide derivatives as PPAR modulators
03/22/2006CN1751036A Substituted 3-(benzoylureido)-thiophene derivatives, method for the production and use thereof
03/22/2006CN1751034A Process for the preparation of bicyclic aromatic amino acids and intermediates thereof
03/22/2006CN1751033A Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for the production thereof
03/22/2006CN1751031A HIV replication inhibiting pyrimidines and triazines
03/22/2006CN1751030A HIV replication inhibiting pyrimidines and triazines
03/22/2006CN1751028A Non-nucleoside reverse transcriptase inhibitors
03/22/2006CN1751025A Diamine derivatives
03/22/2006CN1751023A Piperidine-benzenesulfonamide derivatives
03/22/2006CN1750823A Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/22/2006CN1749256A Novel oxazolidone derivative, its preparing method and use
03/21/2006US7015236 N-(5-isoxazolyl)-4-(trifluoromethyl)nicotinamide; pesticides
03/21/2006US7015235 Acylated piperidine derivatives as melanocortin-4 receptor agonists
03/21/2006US7015223 Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade
03/21/2006US7015220 enzyme inhibitors used as modulators of tyrosine kinase signal transduction and/or as antiproliferative agents; prophylaxis of vision defects, cancer, atherosclerosis, restenosis, metabolic disorders or autoimmune diseases
03/21/2006US7015217 Cyclic sulfone derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)